Search Results

There are 6171 results for: content related to: Porcine circovirus (PCV) removal by Q sepharose fast flow chromatography

  1. You have full text access to this OnlineOpen article
    The first recombinant human coagulation factor VIII of human origin: human cell line and manufacturing characteristics

    European Journal of Haematology

    Volume 89, Issue 2, August 2012, Pages: 165–176, Elisabeth Casademunt, Kristina Martinelle, Mats Jernberg, Stefan Winge, Maya Tiemeyer, Lothar Biesert, Sigurd Knaub, Olaf Walter and Carola Schröder

    Article first published online : 15 JUN 2012, DOI: 10.1111/j.1600-0609.2012.01804.x

  2. Influence of Drug Property and Product Design on In Vitro–In Vivo Correlation of Complex Modified-Release Dosage Forms

    Journal of Pharmaceutical Sciences

    Volume 103, Issue 2, February 2014, Pages: 507–516, Yihong Qiu, Xia Li and John Z. Duan

    Article first published online : 14 DEC 2013, DOI: 10.1002/jps.23804

  3. Basic Concepts for the Development of a Biosimilar Product: Experience with Omnitrope®, the First Ever Approved Similar Biopharmaceutical Product

    Modern Biopharmaceuticals: Recent Success Stories

    Alexander Berghout, Andreas Premstaller, Mark McCamish, Pages: 401–428, 2013

    Published Online : 23 APR 2013, DOI: 10.1002/9783527669417.ch18

  4. You have full text access to this OnlineOpen article
    Biosimilar agents in oncology/haematology: from approval to practice

    European Journal of Haematology

    Volume 86, Issue 4, April 2011, Pages: 277–288, Dietger Niederwieser and Stephan Schmitz

    Article first published online : 25 JAN 2011, DOI: 10.1111/j.1600-0609.2010.01566.x

  5. You have full text access to this OnlineOpen article
    A Comprehensive Drug Safety Evaluation of Pregabalin in Peripheral Neuropathic Pain

    Pain Practice

    Rainer Freynhagen, Michael Serpell, Birol Emir, Ed Whalen, Bruce Parsons, Andrew Clair and Mark Latymer

    Article first published online : 27 NOV 2013, DOI: 10.1111/papr.12146

  6. Contact dermatitis as an adverse reaction to some topically used European herbal medicinal products – part 1: Achillea millefolium–Curcuma longa

    Contact Dermatitis

    Volume 71, Issue 1, July 2014, Pages: 1–12, Gioacchino Calapai, Marco Miroddi, Paola L. Minciullo, Achille P. Caputi, Sebastiano Gangemi and Richard J. Schmidt

    Article first published online : 13 MAR 2014, DOI: 10.1111/cod.12222

  7. Clinical Trials—Collecting Safety Data and Establishing the Adverse Drug Reactions Profile

    Stephens' Detection and Evaluation of Adverse Drug Reactions: Principles and Practice, Sixth Edition

    John Talbot, Marianne Keisu, Lars Ståhle, Pages: 215–289, 2012

    Published Online : 30 JAN 2012, DOI: 10.1002/9780470975053.ch4

  8. You have full text access to this OnlineOpen article
    Concordance of preclinical and clinical pharmacology and toxicology of therapeutic monoclonal antibodies and fusion proteins: cell surface targets

    British Journal of Pharmacology

    Volume 166, Issue 3, June 2012, Pages: 823–846, Peter J Bugelski and Pauline L Martin

    Article first published online : 8 MAY 2012, DOI: 10.1111/j.1476-5381.2011.01811.x

  9. Review article: biosimilars are the next generation of drugs for liver and gastrointestinal diseases

    Alimentary Pharmacology & Therapeutics

    Volume 38, Issue 8, October 2013, Pages: 914–924, M. Rinaudo-Gaujous, S. Paul, E. D. Tedesco, C. Genin, X. Roblin and L. Peyrin-Biroulet

    Article first published online : 3 SEP 2013, DOI: 10.1111/apt.12477

  10. Role of modeling and simulation in pediatric investigation plans

    Pediatric Anesthesia

    Volume 21, Issue 3, March 2011, Pages: 214–221, Efthymios Manolis, Tariq Eldirdiry Osman, Ralf Herold, Franz Koenig, Paolo Tomasi, Spiros Vamvakas and Agnes Saint Raymond

    Article first published online : 18 JAN 2011, DOI: 10.1111/j.1460-9592.2011.03523.x

  11. You have full text access to this OnlineOpen article
    Concordance of preclinical and clinical pharmacology and toxicology of monoclonal antibodies and fusion proteins: soluble targets

    British Journal of Pharmacology

    Volume 166, Issue 3, June 2012, Pages: 806–822, Pauline L Martin and Peter J Bugelski

    Article first published online : 8 MAY 2012, DOI: 10.1111/j.1476-5381.2011.01812.x

  12. New pathway for qualification of novel methodologies in the European medicines agency

    PROTEOMICS - Clinical Applications

    Volume 5, Issue 5-6, June 2011, Pages: 248–255, Efthymios Manolis, Spiros Vamvakas and Maria Isaac

    Article first published online : 28 APR 2011, DOI: 10.1002/prca.201000130

  13. The International ADHD in Substance Use Disorders Prevalence (IASP) study: background, methods and study population

    International Journal of Methods in Psychiatric Research

    Volume 22, Issue 3, September 2013, Pages: 232–244, Geurt van de Glind, Katelijne Van Emmerik-van Oortmerssen, Pieter Jan Carpentier, Frances R. Levin, Maarten W.J. Koeter, Csaba Barta, Sharlene Kaye, Arvid Skutle, Johan Franck, Maija Konstenius, Eli-Torild Bu, Franz Moggi, Geert Dom, Zolt Demetrovics, Mélina Fatséas, Arild Schillinger, Máté Kapitány-Fövény, Sofie Verspreet, Andrea Seitz, Brian Johnson, Stephen V. Faraone, J. Antoni Ramos-Quiroga, Steve Allsop, Susan Carruthers, Robert A. Schoevers, Iasp Research Group and Wim van den Brink

    Article first published online : 11 SEP 2013, DOI: 10.1002/mpr.1397

  14. Optimized Nonclinical Safety Assessment Strategies Supporting Clinical Development of Therapeutic Monoclonal Antibodies Targeting Inflammatory Diseases

    Drug Development Research

    Volume 75, Issue 3, May 2014, Pages: 115–161, Frank R. Brennan, Annick Cauvin, Jay Tibbitts and Alison Wolfreys

    Article first published online : 29 APR 2014, DOI: 10.1002/ddr.21173

  15. A fresh perspective on comparing the FDA and the CHMP/EMA: approval of antineoplastic tyrosine kinase inhibitors

    British Journal of Clinical Pharmacology

    Volume 76, Issue 3, September 2013, Pages: 396–411, Rashmi R. Shah, Samantha A. Roberts and Devron R. Shah

    Article first published online : 20 AUG 2013, DOI: 10.1111/bcp.12085

  16. Biosimilars: how similar?

    Internal Medicine Journal

    Volume 44, Issue 3, March 2014, Pages: 218–223, V. Strand and B. Cronstein

    Article first published online : 13 MAR 2014, DOI: 10.1111/imj.12292

  17. Quality Assurance Requirements in Plasma Product Manufacture

    Production of Plasma Proteins for Therapeutic Use

    Joseph Bertolini, Neil Goss, John Curling, Pages: 381–401, 2012

    Published Online : 14 DEC 2012, DOI: 10.1002/9781118356807.ch28

  18. You have free access to this content
    Appendix 5: The New EU Risk Management Plan

    Pharmacovigilance Medical Writing: A Good Practice Guide

    Justina Orleans-Lindsay, Pages: 215–225, 2012

    Published Online : 19 JUN 2012, DOI: 10.1002/9781118301906.app5

  19. Application of Dried Blood Spot Sampling in Clinical Pharmacology Trials and Therapeutic Drug Monitoring

    Dried Blood Spots: Applications and Techniques

    Kenneth Kulmatycki, Wenkui Li, Xiaoying (Lucy) Xu, Venkateswar Jarugula, Pages: 216–228, 2014

    Published Online : 13 JUN 2014, DOI: 10.1002/9781118890837.ch19

  20. Quantification of insulin

    Diabetic Medicine

    Volume 31, Issue 3, March 2014, Pages: 375–376, M. Takayama, K. Yamauchi and T. Aizawa

    Article first published online : 16 FEB 2014, DOI: 10.1111/dme.12337